Background: Thinking about greater adherence to dietary planning, it is extremely important to be aware of all nutritional strategies and dietary prescriptions available in the literature, and of which of them is the most efficient for the management of T2DM. Methods: A search was carried out in 2023 for randomized clinical trials, systematic reviews, meta-analyses, and guidelines in the following databases: Pubmed, Scielo, Web of Science, CrossRef and Google Scholar. In total, 202 articles were collected and analyzed. The period of publications was 1983–2023. Results: There is still no consensus on what the best nutritional strategy or ideal dietary prescription is, and individuality is necessary. In any case, these references suggest that Mediterranean Diet may of greater interest for the management of T2DM, with the following recommended dietary prescription: 40–50% carbohydrates; 15–25% proteins; 25–35% fats (<7% saturated, 10% polyunsaturated, and 10% monounsaturated); at least 14 g of fiber for every 1000 kcal consumed; and <2300 mg sodium. Conclusions: Individuality is the gold standard for dietary prescriptions, however, the Mediterranean diet with low levels of carbohydrates and fats seems to be the most promising strategy for the management of T2DM.

Introduction: Binge eating disorder (BED) is a psychiatric illness related to a high frequency of episodes of binge eating, loss of control, body image dissatisfaction, and suffering caused by overeating. It is estimated that 30% of patients with BED are affected by obesity. “Mindful eating” (ME) is a promising new eating technique that can improve self-control and good food choices, helping to increase awareness about the triggers of binge eating episodes and intuitive eating training. Objectives: To analyze the impact of ME on episodes of binge eating, body image dissatisfaction, quality of life, eating habits, and anthropometric data [weight, Body Mass Index (BMI), and waist circumference] in patients with obesity and BED. Method: This quantitative, prospective, longitudinal, and experimental study recruited 82 patients diagnosed with obesity and BED. The intervention was divided into eight individual weekly meetings, guided by ME sessions, nutritional educational dynamics, cooking workshops, food sensory analyses, and applications of questionnaires [Body Shape Questionnaire (BSQ); Binge Eating Scale (BES); Quality of Life Scale (WHOQOL-BREF)]. There was no dietary prescription for calories, carbohydrates, proteins, fats, and fiber. Patients were only encouraged to consume fewer ultra-processed foods and more natural and minimally processed foods. The meetings occurred from October to November 2023. Statistical analysis: To carry out inferential statistics, the Shapiro–Wilk test was used to verify the normality of variable distribution. All variables were identified as non-normal distribution and were compared between the first and the eighth week using a two-tailed Wilcoxon test. Non-Gaussian data were represented by median ± interquartile range (IQR). Additionally, α < 0.05 and p < 0.05 were adopted. Results: Significant reductions were found from the first to the eighth week for weight, BMI, waist circumference, episodes of binge eating, BSQ scale score, BES score, and total energy value (all p < 0.0001). In contrast, there was a significant increase in the WHOQOL-BREF score and daily water intake (p < 0.0001). Conclusions: ME improved anthropometric data, episodes of binge eating, body image dissatisfaction, eating habits, and quality of life in participants with obesity and BED in the short-term. However, an extension of the project will be necessary to analyze the impact of the intervention in the long-term.

Introduction: Nutritional management plays a crucial role in treating patients with type 2 diabetes (T2D), working to prevent and control the progression of chronic non-communicable diseases. Objectives: To evaluate the effects of individualized nutritional interventions on weight, body mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHR), fasting blood glucose (FBG), hemoglobin A1c (HbA1c), total cholesterol (TC), LDL cholesterol (LDL-C), HDL cholesterol (HDL-C), triglycerides (TGs), systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR)} over 12 months and subsequently at follow-up (15 months). Methods: This longitudinal experimental study (without randomization and blinding) enrolled 84 sedentary participants with T2D (both sexes, aged 18–80 years). They were divided into a control group of 40 participants who received only medical consultations, and an intervention group of 44 participants who received the same medical care along with a nutritional assessment. Consultations occurred quarterly from August 2020 to November 2022 (first–twelfth month), with six to nine patients per session. Subsequently, a follow-up was conducted from December 2022 to November 2023, during which the intervention group had only medical care (during the 12th–15th months). Personalized dietary planning was inspired by the Mediterranean/DASH diets adapted to Brazilian foods and socioeconomic cultures. Statistical Analysis: Normal variables were compared between groups for each time point and also within each group across different time points using a two-way ANOVA (repeated measures for intragroup) followed by the Šídák post hoc test. Non-normal variables were compared between groups for each time point using Kruskal–Wallis followed by the Dunn post hoc test, and within each group across different time points using Friedman followed by the Dunn post hoc test. Data with a Gaussian distribution were presented as mean ± standard deviation (SD), and data with a non-Gaussian distribution were presented as median ± interquartile range (IQR). For all cases, α < 0.05 and p < 0.05 were adopted. Results: In the intervention group, significant reductions were observed between the first and twelfth month for all parameters (p < 0.05), (except for TC), along with an increase in HDL-C (p = 0.0105). Conversely, in the control group, there was a significant increase in HbA1c, weight, BMI, FBG, and WHR (p < 0.05) between the first and twelfth months. Regarding the comparison between groups, there was a significant difference for all analyzed parameters (p < 0.05) from the first to the twelfth month. In the follow-up, differences were also observed (p < 0.05), except for BMI (p > 0.05). Conclusion: The individualized nutritional intervention improved eating habits, anthropometric, biochemical, and cardiovascular markers in T2D over 12 months, with sustained results during follow-up. The dietary plan inspired by the Mediterranean and DASH diets demonstrated good adaptation to the Brazilian food culture and the patients’ socioeconomic contexts. Consistent monitoring and personalized nutritional management are essential for optimizing long-term outcomes. However, more clinical trials are necessary in order to optimize the level of evidence for longitudinal interventions.

Obesity is a complex chronic disease that affects millions of people worldwide. There is still significant stigma associated with it, which can lead to discrimination and create additional barriers for people who are already in treatment. On the other hand, it is noted that it can have serious implications for health and predisposition to noncommunicable chronic diseases. In this sense, the objective of this study was to carry out a narrative review involving all current elements for understanding, prevention, treatment, and debate of stigmas related to obesity. A search was conducted in 2024 for original articles, randomized or nonrandomized clinical trials, systematic reviews, meta-analyses, and guidelines in the following databases: Pubmed, Scielo, Web of Science, CrossRef, and Google Scholar. The publication period was from 2014 to 2024. Obesity is influenced by a complex combination of genetic, environmental, and psychological factors. It is encouraging to see that various emerging points have been identified across different fields such as histology, physiology, genetics, weight loss, and public policy. These obesity areas certainly warrant attention and future studies. Researchers can delve into these topics to deepen their understanding and potentially uncover novel insights. The management should be multifactorial and individualized for each patient. Public policies also play a crucial role in combating obesity, including health promotion, prevention of excessive weight gain, early diagnosis, and proper care of patients. It is crucial that society begins to see the disease as an extremely complex element and not as a moral failure or lack of willpower. This requires a change in the way people talk about obesity, as well as practices that support people instead of stigmatizing them. Obesity does not have a specific address, color, or race. It belongs to everyone and should be regarded as a global public health problem.

Background and aims: There is ongoing debate about the optimal macronutrient and micronutrient proportions for treating type 2 diabetes (T2D) and hypertension. The objective of this study was to evaluate the dietary composition of patients participating in a 12-month interventional study with follow-up. Additionally, it aimed to evaluate the interactions and correlations between diet components and anthropometric markers, laboratory markers, and blood pressure (BP). Finally, perform a qualitative analysis of daily and postmeal satiety. Methods: This experimental, analytical, and correlational study is a quaternary evaluation within a recently published longitudinal research. Eighty-four participants were divided into two groups: intervention: followed a Mediterranean-DASH diet for 12 months with follow-up at 15 months; control: no dietary changes. Parametric variables were compared using two-way ANOVA and Tukey post hoc test. Nonparametric variables were compared using Kruskal–Wallis with Dwass–Steel–Critchlow–Fligner post hoc test and Friedman with Durbin–Conover post hoc test. Parametric data were represented as mean ± standard deviation, nonparametric as median ± interquartile range. Linear regression was used for interaction/relation analysis, and Pearson test for correlation. Significance was P less than 0.05. Results: Initially, both groups consumed diets high in ultra-processed foods, rich in refined carbohydrates, saturated fats, and sodium. At the 12th visit and follow-up, the intervention group showed substantial improvement in diet quality and dietary requirements (P < 0.05). The control group maintained or worsened their diet quality (P < 0.05). At first, both groups reported high hunger and low satiety. By the 12th month, the intervention group showed significant improvements, with 88.6% reporting postmeal fullness and 75% experiencing daily satiety. Significant positive and negative correlations (P < 0.05) were observed in both groups. In the control group, low-density lipoprotein cholesterol (LDL-C) was correlated with trans fats and proteins; high-density lipoprotein cholesterol (HDL-C) with polyunsaturated fats; total cholesterol (TC) with proteins and monounsaturated fats; and glycated hemoglobin (HbA1c) with fibers. In the intervention group, BMI was correlated with carbohydrates; HbA1c with total fats; LDL-C with carbohydrates; glucose with proteins; TC with total fats and carbohydrates; HDL-C with total fats, polyunsaturated fats, and saturated fats; glucose with monounsaturated fats (P < 0.05). In the intervention group, BP, heart rate, plasma, and urinary sodium levels significantly improved over time (P < 0.05). However, no strong correlations between sodium intake and these markers were observed (P > 0.05). In contrast, the control group showed no significant changes in BP, heart rate, plasma, or urinary sodium levels over time (P > 0.05), nor were there any strong correlations between sodium intake and these markers (P > 0.05). Notably, SBP, plasma, and urinary sodium levels demonstrated a significant difference between groups from the 12th month to the follow-up (P < 0.05). Additionally, DBP differed significantly from baseline, with the intervention group initially presenting higher values, which reversed by the 12th month and persisted until follow-up (P < 0.05). Conclusion: The Mediterranean-DASH diet improved anthropometric, laboratory parameters, and BP in T2D and hypertension over the 12-month intervention and follow-up, whereas the ultra-processed diet worsened some of these markers. The intervention also improved satiety levels throughout the day. The quality and quantity of the diet are proportionally correlated to the anthropometric and laboratory markers. No significant strong correlations were found between plasma and urinary sodium levels, BP, or heart rate with sodium intake; only trends were observed. Nonetheless, further clinical trials are needed to establish causality, and the findings should be interpreted with caution due to the study's limitations.